BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

eXegenics Inc. (Formerly Known As Cytoclonal Pharmaceutics) 

2110 Research Row

Dallas  Texas  75235  U.S.A.
Phone: 214-358-2000 Fax: 214-350-9514


SEARCH JOBS


Industry
Biotechnology






 Company News
eXegenics (EXEG) Reports First Quarter 2004 Results 10/19/2005 5:11:22 PM    More...
eXegenics (EXEG) Reports Year End 2003 Results 10/19/2005 5:10:50 PM    More...
eXegenics (EXEG) Names David E. Riggs President And CEO 10/19/2005 5:10:44 PM    More...
eXegenics (EXEG) Engages BDO Seidman, LLP As New Auditor 10/19/2005 5:10:32 PM    More...
Former Nasdaq CFO Appointed To eXegenics (EXEG) Board; Gordon Martin To Serve On Audit Committee 10/19/2005 5:10:28 PM    More...
eXegenics (EXEG) Announces Dr. Ronald L. Goode Has Resigned From The Company As Chief Executive Officer And President; Quits In Dispute With Board 10/19/2005 5:10:09 PM    More...
The Nasdaq Stock Market Completes Favorable Review Of eXegenics' (EXEG) New Board; Nasdaq Staff Determines That Board And Audit Committee Are Independent 10/19/2005 5:09:52 PM    More...
eXegenics (EXEG) Release: The Nasdaq Stock Market Panel Renders Determination On Listing Of EXEG; Company Gains Extension To July To Regain Compliance 10/19/2005 5:09:44 PM    More...
eXegenics (EXEG) Announces Results Of Consent Solicitation; Five Nominees O The Meyers-Weiss Group Were Elected As Directors Of eXegenics, Replacing The Former Board Of Directors 10/19/2005 5:09:28 PM    More...
eXegenics (EXEG) Responds To Meyers-Weiss Claim 10/19/2005 5:09:27 PM    More...
12

//-->